Get the Stockscreener App
49.55
2.45%
1.04
Omnicell Inc stock is traded at $49.55, with a volume of 206.37K.
It is up +2.45% in the last 24 hours and up +17.24% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
See More
Previous Close:
$48.51
Open:
$48.01
24h Volume:
206.37K
Relative Volume:
0.41
Market Cap:
$2.29B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-64.35
EPS:
-0.77
Net Cash Flow:
$151.63M
1W Performance:
+23.88%
1M Performance:
+17.24%
6M Performance:
+64.95%
1Y Performance:
+63.27%
1-Day Range:
$48.01
$50.20
1-Week Range:
$45.15
$55.74
52-Week Range:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Omnicell's SWOT analysis: healthcare tech firm's stock rides upgrade wave - Investing.com
Omnicell's SWOT analysis: healthcare tech firm's stock rides upgrade wave By Investing.com - Investing.com UK
Omnicell, Inc. (NASDAQ:OMCL) Q3 2024 Earnings Call Transcript - MSN
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? - Benzinga
Omnicell Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next - Simply Wall St
OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised - MSN
Omnicell, Inc. (OMCL) Soars to 52-Week High, Time to Cash Out? - MSN
Rice Hall James & Associates LLC Invests $2.72 Million in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell Appoints Nnamdi Njoku as Executive Vice President and C - GuruFocus.com
Omnicell cut to neutral by BofA, lack of visibility into growth cited - MSN
Omnicell Q3 Earnings: Look At The Growth Segment (NASDAQ:OMCL) - Seeking Alpha
What 5 Analyst Ratings Have To Say About Omnicell - Benzinga
Omnicell (NASDAQ:OMCL) Price Target Raised to $58.00 - MarketBeat
Omnicell stock hits 52-week high at $45.85 amid market rally - Investing.com Australia
Omnicell's (OMCL) "Neutral" Rating Reiterated at Bank of America - MarketBeat
42,461 Shares in Omnicell, Inc. (NASDAQ:OMCL) Acquired by Roubaix Capital LLC - MarketBeat
Omnicell stock downgraded at BofA on growth visibility concerns - Investing.com
Omnicell Inc (OMCL) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance Australia
Omnicell stock downgraded at BofA on growth visibility concerns By Investing.com - Investing.com UK
Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)? - Simply Wall St
Omnicell Inc (OMCL) Q3 2024 Earnings: EPS at $0.19 Beats Estimat - GuruFocus.com
Omnicell Reports Strong Q3 2024 Financial Results - TipRanks
Top Medical Stock Breaks Out After Obliterating Profit Views - Investor's Business Daily
Omnicell stock hits 52-week high at $45.85 amid market rally By Investing.com - Investing.com South Africa
Omnicell soars after bullish quarterly report, outlook - XM
Omnicell (OMCL) Beats Q3 Earnings and Revenue Estimates - MSN
Omnicell Q3 2024 Earnings Preview - MSN
Omnicell (NASDAQ:OMCL) Reaches New 52-Week HighWhat's Next? - MarketBeat
Omnicell earnings beat by $0.14, revenue topped estimates - Investing.com Canada
Omnicell Announces Third Quarter 2024 Results - citybiz
Omnicell (NASDAQ:OMCL) Issues Q4 Earnings Guidance - MarketBeat
Omnicell earnings beat by $0.14, revenue topped estimates By Investing.com - Investing.com South Africa
Omnicell beats Q3 expectations, raises full-year outlook By Investing.com - Investing.com Australia
Omnicell: Q3 Earnings Snapshot - Thehour.com
Omnicell beats Q3 expectations, raises full-year outlook - Investing.com India
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell - Yahoo Finance
3 Medical Info Systems Stocks to Gain From Healthcare Digitization - Yahoo Finance
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
When the Price of (OMCL) Talks, People Listen - Stock Traders Daily
GAM Holding AG Sells 30,371 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell (OMCL) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Omnicell (OMCL) Moves to Strong Buy: Rationale Behind the Upgrade - MSN
Omnicell (NASDAQ:OMCL) Upgraded to Buy at StockNews.com - MarketBeat
New Horizons in Senior Healthcare Medication Services Market - openPR
Central Fill Pharmacy Automation Market Growth in Future Scope - openPR
Wells Fargo & Company Increases Omnicell (NASDAQ:OMCL) Price Target to $41.00 - Defense World
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Position Trimmed by Exchange Traded Concepts LLC - MarketBeat
Is Omnicell, Inc. (NASDAQ:OMCL) The Top Stock With Improving Technical Ratings According To Piper Sandler? - Yahoo Finance
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):